DFDiego Arruda Falcão

Diego Arruda Falcão

*This is an algorithmically generated author record based on publicly available information.

Diego Arruda Falcão has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genomic Insights into the Spread of Vaccinia Virus Strain Cantagalo to Rural Regions of Northeastern Brazil

    by Maria Júlia Cadrieskt-Ribeiro, Matheus Nobrega Luques, Samuel Hir, Pedro Lucas O. Correia, Régis Linhares Oliveira, Carolina Maciel Neves, Keilla Maria P. Silva, Mayara Matias O. M. da Costa, Diego Arruda Falcão, Luciana Bahiense da Costa, et al.

    Vaccinia virus strain Cantagalo (CTGV) causes a pustular disease in dairy cows and milkers in Brazil. Outbreaks in several states have been frequently reported, but the full genome sequence and genomic analysis of isolates from the Northeast region have never been described. Here, we report CTGV outbreaks in two Northeastern states, affecting milkers, lactating cows, and suckling calves. The farms were located in the main dairy belt of Pernambuco, in the Borborema Plateau, and in a rural region of Bahia. Of the 12 samples that tested positive for CTGV, five had their genomes fully sequenced. They cluster with CTGV isolates from Goiás (Midwest region, 2022) and São Paulo (Southeast region, 2023) but diverge from isolates from the Southeast in the early 2000s. Two clinical isolates have accumulated greater genetic variability and segregate separately from the other three isolates from the Northeast, showing evidence of potential recombination events with the FAI-01 isolate from the Midwest region (2022). We also detected Parapoxvirus and CTGV coinfection in some animals. These findings likely suggest different episodes of virus introduction in these states. The spread of CTGV raises concerns about the potential impact on local economic activities and underscores the importance of avoiding raw milk consumption.

  • Open Access

    Case Series of Adverse Pregnancy Outcomes Associated with Oropouche Virus Infection

    by Daniele Barbosa de Almeida Medeiros, Juarez Antônio Simões Quaresma, Raimunda Do Socorro da Silva Azevedo, Ana Cecilia Ribeiro Cruz, Sandro Patroca da Silva, Arnaldo Jorge Martins Filho, Bruno Tardelli Diniz Nunes, Lucas Rafael Santana Pinheiro, Jorge Rodrigues de Sousa, Jannifer Oliveira Chiang, et al.

    The Oropouche virus (OROV) is an arbovirus (Peribunyaviridae: Orthobunyavirus) that traditionally causes febrile outbreaks in Latin America’s Amazon region. Previously, OROV was not associated with severe pregnancy outcomes. During the 2022–2024 outbreak in Brazil, OROV expanded geographically, revealing links to adverse pregnancy outcomes. This study describes six cases with varied fetal outcomes, including miscarriage, antepartum, intrauterine fetal demise (IFD), and normal development, correlating with maternal symptoms but not symptom severity. Vertical transmission was confirmed by detecting OROV through RT-qPCR, ELISA, and immunohistochemistry in fetal tissues. Genome sequencing from an IFD case identified a novel reassortment pattern reported in the 2022–2024 outbreak. Severe encephalomalacia, meningoencephalitis, vascular compromise, and multi-organ damage were evident, underscoring the significant risk OROV poses to fetal development and emphasizing the need for further investigation.


  • Open Access

    LGALS3 +191A and +292C polymorphisms are associated with a reduction in serum gal-3 levels, but not with the clinical events of individuals with sickle cell anemia

    by Kleyton Palmeira Do Ó, Taciana Furtado de Mendonça-Belmont, Isabela Cristina Cordeiro Farias, Andreia Soares da Silva, Ana Karla da Silva Freire, Patrícia Muniz Mendes Freire de Moura, Luydson Richardson Silva Vasconcelos, Aderson da Silva Araújo, Gabriela da Silva Arcanjo, Diego Arruda Falcão, et al.

    Objective: This study aimed to evaluate whether the single nucleotide polymorphisms (SNPs) +191 C>A (rs4644) and +292 A>C (rs4652) of the LGALS3 gene and the serum levels of galectin-3 (gal-3) are associated with clinical events in patients with sickle cell anemia (SCA). Methods: SNP +191 and +292 of the LGALS3 gene were detected by the TaqMan PCR system in real time. Gal-3 levels were measured in serum by ELISA. The study included 322 patients, mean age 36 (21-84). Results: AA and CA genotypes of the +191 region were related to lower levels of gal-3 when compared to CC genotype (p=0.0296). Lower level of gal-3 was also associated with the +191/+292 (AA/CC; CA/CC) diplotypes (p=0.0137) compared to the diplotypes (CC/AA; CC/CC; CC/AC; CA/AC). There was no association between serum levels of galectin-3 and genotype frequencies of the LGALS3 +191 and +292 polymorphisms with clinical events in SCA. Conclusion: The polymorphisms +191 and +292 of the LGALS3 are associated to decrease in serum levels of gal-3. However, no association of polymorphisms and levels of gal-3 with clinical events was observed in patients SCA.


  • Open Access

    MBL2 gene polymorphisms are not related to the occurrence of cerebrovascular disease in sickle cell anemia

    by Isabela Cristina Cordeiro Farias, Taciana Furtado Mendonça-Belmont, Patrícia Muniz Mendes Freire Moura, Igor Farias Domingos, Diego Arruda Falcão, Gabriela Silva Arcanjo, Betânia Lucena Domingues Hatzlhofer, Kleyton Palmeira Do Ó, João Victor Cordeiro Farias, Andreia Soares da Silva, et al.

    Objective: This study has as objective to verify whether MBL2 gene polymorphisms are related to the occurrence of cerebrovascular disease (CD) in sickle cell anemia (SCA) patients. Methods: Overall, 259 unrelated SCA patients were enrolled. The patients were divided into three groups: control group, stroke group ad range of risk group. Peripheral blood samples were collected and DNA extraction was performed. All patients were genotyped for exon 1, promoter region -221 and promoter region -550 of MBL2 gene, along with β-globin gene haplotypes. Results: Concerning the genotyping of the MBL2, there was no difference in the frequency of allelic and genotypic variants of the exon 1 and the promoter regions -221 and -550 of the MBL2 gene among the studied groups. Conclusion: Despite the small number of patients, and the lack of association between MBL2 polymorphisms and CD, our study represents an effort to understand the impact of MBL2 polymorphisms in the clinical outcome of patients with SCA.